Eyevensys Appoints New Board Member, Gerald Cagle

Eyevensys announced that Gerald (Jerry) Cagle, PhD, a former senior vice president and chief scientific officer at Alcon Laboratories, has joined its board of directors.

Dr. Cagle is a highly respected pharmaceutical executive with managerial, technical, and business experience spanning almost 40 years. Dr. Cagle served in key leadership roles for Alcon Laboratories Inc., including positions in clinical research, regulatory affairs, and product development. During the last 13 years at Alcon, he held the position of senior vice president and chief scientific officer, introducing a range of new products. Dr. Cagle holds 28 issued patents in both drug and device areas and has published numerous scientific articles. More recently, he has served on the boards of several life sciences companies.